Logo Helmholtz Zentrum München

Diabetes and Metabolic Diseases

Diabetes is one of the most prevalent common diseases in Germany and estimations of the United Nations have clearly defined it as a global threat to humanity. With its complex appearance due to various genetic and environmental factors involved new research approaches need to be established to develop individualized prediction, prevention and treatment in people and patients. Interdisciplinary and translational research projects are enabled through joint efforts of the Helmholtz Diabetes Center and the Alberta Diabetes Institute each focusing on different aspects of development, progression and therapy of diabetes and its various secondary diseases.

We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.